The impact of large, flexible loans for microenterprises
How to cite
Roth, Ben; Rigol, Natalia. 2025. "The impact of large, flexible loans for microenterprises." AEA RCT Registry. AEARCTR-0017099. https://doi.org/10.1257/rct.17099-1.0
Download: BibTeX · RIS — for reference managers without a browser translator. Zotero and most others pick up this page's citation metadata directly.
* Primary investigator
Abstract
In this study, we use a randomized controlled trial in Tamil Nadu, India to evaluate the impact of a new loan product that is two to three times larger than a typical microfinance loan. The loan is targeted at borrowers who have taken near the maximum loan size and now seek larger loans to make capital investments or grow their businesses. The loans also have flexibility features, including repayment frequency options and the ability to take a grace period. We use primary and secondary data to quantity the impact of the new product on men's and women's business activity, income generation, and women's empowerment, as well as additional surveying with business employees and customers to evaluate spillover effects.
Intervention
The loans provided as part of the study are between 2,400 and 3,600 USD, which is equal to two to three times the maximum size of the standard microfinance loan offered by the partner MFI. These individual liability loans last between one and three years and have an interest rate of 22% APR. Borrowers are also able to choose the frequency of repayment – weekly, biweekly, or monthly - and have the option for a grace period whereby borrowers only need to pay the interest due during the first three months of the loan. The loans also include life and health insurance for the business owner. They are intended for borrowers to purchase a fixed asset to either expand their existing business or, in a few cases, to begin a business based on the skills that the borrower has developed as a wage worker.
Experimental design
1,000 individuals will be enrolled in the study, with 500 randomly assigned to the treatment group and 500 randomly assigned to the control group. Recruitment will happen through SHGs, and randomization will be assigned at the level of the SHG. To evaluate impact, we will use an in-person baseline, midline, and endline. We will also capture spillover effects using surveys conducted with customers and employees of the businesses. This will happen at the same time as the midline. We will also use secondary data from the partner MFI to evaluate outcomes.
Design details
Cited by
No citation data available for this registration yet.